Response to “Letter Regarding: Anti-RANKL Antibody for Active Charcot Foot Neuro-osteoarthropathy in Patients With Diabetes and Chronic Kidney Disease”
Restricted accessLetterFirst published online January, 2025
Response to “Letter Regarding: Anti-RANKL Antibody for Active Charcot Foot Neuro-osteoarthropathy in Patients With Diabetes and Chronic Kidney Disease”
AutierPGandiniSMullieP.A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab. 2012;97(8):2606-2613. doi:10.1210/jc.2012-1238
2.
CiprianiCRomagnoliEScillitaniA, et al. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab. 2010;95:4771-4777. doi:10.1210/jc.2010-0502
3.
KayRDForslundJArthurD’TaylorAJAminianA.Prevalence of vitamin D deficiency in patients with Charcot arthropathy: a single-center analysis. J Am Acad Orthop Surg Glob Res Rev. 2022;6(10):e22.00162. doi:10.5435/JAAOSGlobal-D-22-00162
4.
MartinazziBJLorenzFJNamH, et al. Vitamin D deficiency is associated with Charcot neuroarthropathy: a case-control study. Foot Ankle Orthop. 2022;7(4):2473011421S00785. doi:10.1177/2473011421S00785
5.
RastogiASinghRGhoshJGuptaR.Anti-RANKL antibody for active Charcot foot neuro-osteoarthropathy in patients with diabetes and chronic kidney disease. Foot Ankle Int. 2024;45(10):1122-1130. doi:10.1177/10711007241268147
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.